Clinical trial Recruiting at 1 site Interventional

Comparing Ceriter Stride-One smart insoles with GRAIL gait measurements

Official title: Comparing the Ceriter Stride One, a Pressure-sensitive Smart Insole, With Gait Parameters Measured on the GRAIL in Neurological Populations

Run by University Hospital, Ghent · NCT07237386 · Data updated 2026-11-12

We will test whether Ceriter Stride-One pressure-sensitive insoles give the same gait measurements as the GRAIL system for people with stroke, incomplete spinal cord injury, or acquired/traumatic brain injury who can walk independently for at least six minutes.

More Stroke trials

Quick facts

Study typeInterventional
SexAll
Enrollment30 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations1 site (Ghent)
StatusRecruiting
StartedOctober 15, 2025
Main results expectedSeptember 1, 2026
Study endsOctober 1, 2026
Registry record updatedNovember 19, 2025
Trial IDNCT07237386 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with central nervous system lesions (stroke, incomplete spinal cord injury, or acquired/traumatic brain injury) receiving care at the Ghent rehabilitation center who can walk independently for at least six minutes are ideal candidates.

Probably not a fit

Patients with severe lower-limb orthopedic trauma, body weight over 120 kg, severe dizziness or cardiopulmonary disorders that prevent safe standing/exercise, or who cannot understand the task are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants who are in rehabilitation for stroke, incomplete spinal cord injury, or acquired/traumatic brain injury will wear Ceriter Stride-One smart insoles while undergoing standard gait assessment on the GRAIL instrumented treadmill at UZ Ghent. The study will compare matching parameters such as support phase, swing phase, and left/right leg pressure recorded by the insoles and the GRAIL. Agreement between the two measurement systems will be analyzed to determine the insoles' accuracy. Results will inform whether these insoles can be used reliably in clinical practice and future outpatient or real-world gait monitoring studies.

Why it matters

Potential benefit: If successful, validated insoles could provide accurate, real-world gait data outside the lab to guide personalized rehabilitation and remote monitoring.

How similar studies have gone: Previous studies of wearable pressure insoles have shown reasonable agreement with lab-based gait systems in some populations, but validation specifically in these neurological rehabilitation groups is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Persons suffering a lesion of the central nervous system (stroke, incomplete spinal cord injury, acquired brain injury) who are admitted to the rehabilitation center of the Ghent University hospital or who follow therapy at the rehabilitation center of the Ghent University hospital as outpatients.
* Patients need to be able to walk independently during at least 6 minutes without the need of an extra person (Functional ambulation category 3 or higher).

Exclusion Criteria:

* Severe orthopedic trauma or acute trauma of the lower limbs influencing walking
* body weight that exceeds 120 kg.
* severe dizziness that makes exercising in standing position impossible
* severe cardio-pulmonary disorders that require monitoring during exercising
* patients who do not understand the task that needs to be performed in this study.

Where it's running

  • University Hospital Ghent
    Ghent, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.